These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
822 related articles for article (PubMed ID: 26547126)
1. Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: A meta-analysis. Wei J; Pei S; Zhu X Oral Oncol; 2016 Jan; 52():11-7. PubMed ID: 26547126 [TBL] [Abstract][Full Text] [Related]
2. FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review. Liu T; Xu W; Yan WL; Ye M; Bai YR; Huang G Radiother Oncol; 2007 Dec; 85(3):327-35. PubMed ID: 18037523 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive imaging of residual/ recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT. Ng SH; Chan SC; Yen TC; Liao CT; Chang JT; Ko SF; Wang HM; Lin CY; Chang KP; Lin YC Eur Radiol; 2010 Sep; 20(9):2229-40. PubMed ID: 20393714 [TBL] [Abstract][Full Text] [Related]
4. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography: comparison with 18-fluoro-2-deoxyglucose positron emission tomography. Kao CH; Shiau YC; Shen YY; Yen RF Cancer; 2002 Apr; 94(7):1981-6. PubMed ID: 11932900 [TBL] [Abstract][Full Text] [Related]
5. Comparing 18-fluoro-2-deoxyglucose positron emission tomography with a combination of technetium 99m tetrofosmin single photon emission computed tomography and computed tomography to detect recurrent or persistent nasopharyngeal carcinomas after radiotherapy. Kao CH; Tsai SC; Wang JJ; Ho YJ; Yen RF; Ho ST Cancer; 2001 Jul; 92(2):434-9. PubMed ID: 11466699 [TBL] [Abstract][Full Text] [Related]
6. [Meta-analysis of PET/CT for diagnosis of residual/recurrent nasopharyngeal carcinoma]. Shen G; Zhou L; Jia Z; Zhang W; Wang Q; Deng H Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 29(1):61-7. PubMed ID: 25966558 [TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET/CT for the Diagnosis of Residual or Recurrent Nasopharyngeal Carcinoma After Radiotherapy: A Metaanalysis. Zhou H; Shen G; Zhang W; Cai H; Zhou Y; Li L J Nucl Med; 2016 Mar; 57(3):342-7. PubMed ID: 26541775 [TBL] [Abstract][Full Text] [Related]
8. Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence. Ng SH; Joseph CT; Chan SC; Ko SF; Wang HM; Liao CT; Chang YC; Lin WJ; Fu YK; Yen TC J Nucl Med; 2004 Oct; 45(10):1669-76. PubMed ID: 15471831 [TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of diagnostic value of 18F-FDG PET or PET/CT for detecting lymph node and distant metastases in patients with nasopharyngeal carcinoma. Shen G; Zhang W; Jia Z; Li J; Wang Q; Deng H Br J Radiol; 2014 Dec; 87(1044):20140296. PubMed ID: 25348201 [TBL] [Abstract][Full Text] [Related]
10. Usefulness of 201TL SPECT/CT relative to 18F-FDG PET/CT in detecting recurrent skull base nasopharyngeal carcinoma. Yen RF; Ting LL; Cheng MF; Wu YW; Tzen KY; Hong RL Head Neck; 2009 Jun; 31(6):717-24. PubMed ID: 19189341 [TBL] [Abstract][Full Text] [Related]
11. Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis. Liu F; Zhang Q; Zhu D; Liu F; Li Z; Li J; Wang B; Zhou D; Dong J Medicine (Baltimore); 2015 Sep; 94(36):e1462. PubMed ID: 26356700 [TBL] [Abstract][Full Text] [Related]
12. Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT. Comoretto M; Balestreri L; Borsatti E; Cimitan M; Franchin G; Lise M Radiology; 2008 Oct; 249(1):203-11. PubMed ID: 18710963 [TBL] [Abstract][Full Text] [Related]
13. Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging. Chan SC; Ng SH; Chang JT; Lin CY; Chen YC; Chang YC; Hsu CL; Wang HM; Liao CT; Yen TC Eur J Nucl Med Mol Imaging; 2006 Sep; 33(9):1032-40. PubMed ID: 16622711 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic Value of (18)F-FDG PET/CT in Detecting Local Recurrent Colorectal Cancer: A Pooled Analysis of 26 Individual Studies. Yu T; Meng N; Chi D; Zhao Y; Wang K; Luo Y Cell Biochem Biophys; 2015 Jun; 72(2):443-51. PubMed ID: 25737131 [TBL] [Abstract][Full Text] [Related]
15. Comparison of 18F-FDG PET/CT with bone scintigraphy for detection of bone metastasis: a meta-analysis. Cheng X; Li Y; Xu Z; Bao L; Li D; Wang J Acta Radiol; 2011 Sep; 52(7):779-87. PubMed ID: 21712464 [TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis. Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513 [TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography/computed tomography outperforms MRI in the diagnosis of local recurrence and residue of nasopharyngeal carcinoma: An update evidence from 44 studies. Li Z; Li Y; Li N; Shen L Cancer Med; 2019 Jan; 8(1):67-79. PubMed ID: 30578604 [TBL] [Abstract][Full Text] [Related]
18. 18-fluoro-2-deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging. Yen RF; Hung RL; Pan MH; Wang YH; Huang KM; Lui LT; Kao CH Cancer; 2003 Jul; 98(2):283-7. PubMed ID: 12872346 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic Accuracy of 18F-FDG-PET/CT and MRI in Predicting the Tumor Response in Locally Advanced Cervical Carcinoma Treated by Chemoradiotherapy: A Meta-Analysis. Sanei Sistani S; Parooie F; Salarzaei M Contrast Media Mol Imaging; 2021; 2021():8874990. PubMed ID: 33746650 [TBL] [Abstract][Full Text] [Related]
20. Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best?--a meta-analysis. Liu T; Xu JY; Xu W; Bai YR; Yan WL; Yang HL Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):350-8. PubMed ID: 21094027 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]